cobas® click
Confidence you can hear – performance you can trust.
The cobas® click system is an intuitive, next-generation Point of Care (POC) solution for HbA1c, lipids and CRP testing with unique, high-performing test discs that secure with a click.1-9
In today’s fast-paced healthcare environment, you need tools that deliver fast results you can trust. That is where cobas® click comes in. Designed for decentralised settings, from pharmacies and doctor’s offices to clinics, cobas® click aims to support you wherever you are.
Building on a legacy of trust
cobas click builds on the strong foundation of the proven cobas® b 101 system.10,11 It brings advanced features for enhanced performance and even more ease-of-use to help improve patient care.
Single test results are available in about 4-6 minutes. Dual testing results are available within 15 minutes.2-4
- HbA1c: Improve long-term glycaemic control with accurate HbA1c measurement.
- Lipids: Enhance lipid testing with a built-in triglyceride (TG) failsafe mechanism to reduce interferences with triglyceride measurements.
- CRP: Support antimicrobial stewardship and help ensure patients receive the appropriate treatment with the help of cost-effective POC testing.
Introducing the new cobas click system
Discover the intuitive 3-in-1 clinical chemistry POC solution with unique, high-performing test discs that secure with a click.
Discover the ease-of-use of the cobas® click system
The cobas click system was designed to simplify testing and is convenient for everyday use.
References
- F. Hoffmann-La Roche Ltd. cobas® click User Assistance. (v1.0). 2025.
- F. Hoffmann-La Roche Ltd. cobas® CRP Test Gen. 2 Method Sheet. (v1.0). 2024.
- F. Hoffmann-La Roche Ltd. cobas® Lipid Panel Gen. 2 Method Sheet. (v1.0). 2024.
- F. Hoffmann-La Roche Ltd. cobas® HbA1c Test Gen. 2 Method Sheet. (v1.0). 2024.
- 1 Lutz-Haberkern A, et al. Presented at: EuroMedLab; 2025 May18-22; Brussels. Abstract #P2348.
- Scharnhorst V, et al. A multicenter evaluation of a point of care CRP Test. Clin Biochem. 2019;71:38–45.
- Van Hoovels L, et al. Analytical performance and user-friendliness of four commercially available point-of-care devices for C-reactive protein. Clin Chim Acta. 2024;560:119737.
- Singh P, et al. Presented at: EASD Annual Meeting; 2024 Sep 10–13; Madrid. Presentation #802.
- Li B, et al. Verification of point-of-care analysers for C-reactive protein, lipid studies and glycated haemoglobin. Pathology. 2023;55(7):989-999.
- F. Hoffmann-La Roche Ltd. Data on file. Status May 2025.
- F. Hoffmann-La Roche Ltd. cobas® b 101 Operator’s Manual (v2.1). 2023.
- Fedder D, et al. New National Cholesterol Education Program III Guidelines for Primary Prevention Lipid-Lowering Drug Therapy Circulation. 2002;145:e971–7.
- McEnroe RJ et al. CLSI EP 05 Evaluation of Precision Performance of Quantitative Measurement Methods. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
- Lenters-Westera et al. Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation. Clin Chem. 2025;71(7):755-788.